Bosh sahifaHYPE3 • BVMF
add
Hypera SA
Yopilish kursi
23,66 R$
Kunlik diapazon
23,54 R$ - 24,08 R$
Yillik diapazon
15,74 R$ - 28,20 R$
Bozor kapitalizatsiyasi
14,99 mlrd BRL
Oʻrtacha hajm
2,91 mln
Narx/foyda
18,31
Dividend daromadliligi
4,01%
Asosiy maydon
BVMF
Bozor yangiliklari
The Globe and Mail
1 kun oldin
PesoRama Secures TSXV Approval for Equity Financing with Clarifications
1,96%
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (BRL) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 2,23 mlrd | 16,25% |
Joriy xarajat | 688,45 mln | -1,18% |
Sof foyda | 457,64 mln | 21,59% |
Sof foyda marjasi | 20,55 | 4,63% |
Har bir ulushga tushum | 0,72 | 22,03% |
EBITDA | 728,99 mln | 32,89% |
Amaldagi soliq stavkasi | -1,29% | — |
Balans
Jami aktivlari
Jami passivlari
| (BRL) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 1,86 mlrd | -41,91% |
Jami aktivlari | 25,15 mlrd | -2,78% |
Jami passivlari | 12,90 mlrd | -5,53% |
Umumiy kapital | 12,26 mlrd | — |
Tarqatilgan aksiyalar | 632,94 mln | — |
Narxi/balansdagi bahosi | 1,22 | — |
Aktivlardan daromad | 6,82% | — |
Kapitaldan daromad | 7,89% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (BRL) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 457,64 mln | 21,59% |
Operatsiyalardan naqd pul | 853,58 mln | 15,65% |
Sarmoyadan naqd pul | -121,70 mln | 11,59% |
Moliyadan naqd pul | -71,73 mln | 68,53% |
Naqd pulning sof oʻzgarishi | 660,15 mln | 77,22% |
Boʻsh pul | 506,49 mln | 27,43% |
Haqida
Hypera Pharma is a Brazilian multinational pharmaceutical
company and is the largest Brazilian pharmaceutical company by market capitalization. Headquartered in São Paulo, its business include pharmaceuticals, consumer healthcare and cosmetics products, and biotechnology products. Wikipedia
Tashkil etilgan
2001
Bosh ofis
Sayt
Xodimlar soni
10 481
